Prokarium

About Prokarium

Prokarium is a biopharmaceutical company pioneering microbial immunotherapy and synthetic biology to develop innovative cancer treatments. Their mission is to transform precision medicine with sustainable, accessible, and effective immunotherapies, with a lead program in clinical trials for bladder cancer.

Products & Services

ZH9 - Bladder Cancer (Non-Muscle Invasive):A treatment for non-muscle invasive bladder cancer, currently in Phase 1 trials in the US.

Immunotherapy (IO) Prime:A first-in-class oral immune training agent aimed at restoring immune fitness to boost immunotherapy efficacy for cancer patients.

Living Cures Platform:A proprietary synthetic biology platform for novel immunotherapies, designed to deliver diverse therapeutic cargo for difficult-to-treat cancers.

Specialties

Microbial Immunotherapy Synthetic Biology Cancer Treatments Bladder Cancer Immunotherapy Precision Medicine

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Financing T: - FT: Financing	A: 30000000 MR: - FA: $30 million FAN: 30000000	D: 2023-02-09 FD: 2023-02-09	1 investors

Financing Latest

2023-02-09

$30.0M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

I

Ibs Mahmood

Chief Executive Officer

L

Livija Deban

Chief Scientific Officer

D

Dara Henry

COO

J

Josi Holz

CMO

J

Julia Jones

CFO

P

Peter Juul Madsen

Vice President of Chemistry, Manufacturing and Controls (CMC)

View 15 more team members with Pro

Unlock Full Team Directory

Recent News

Prokarium Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised